Advertisement

Bleomycin

  • C. W. Haidle
  • R. S. Lloyd
Part of the Antibiotics book series (ANTIBIOTICS, volume 5 / 2)

Abstract

There have been many useful reviews published during the past few years concerning both the clinical and basic scientific aspects of research on the antineoplastic antibiotic, bleomycin. Umezawa, the discoverer of bleomycin (Umezawa et al., 1966) has written several reviews dealing primarily with the chemistry, structure, in vitro, and in vivo studies of bleomycin (Umezawa, 1975, 1976). Other articles dealing more specifically with the extracellular reaction between bleomycin and cellular macromolecules have appeared recently (Miyaki and Ono, 1976; Müller and Zahn, 1976a, 1977; Müller et al., 1976). Review articles have also been published concerning research on the effects of bleomycin on mammalian cell cultures and cell-cycle kinetics (Barranco and Humphrey, 1976; Terasima et al., 1976). An exhaustive review of the literature on both basic scientific studies and clinical studies has been prepared by Crooke and Bradner (1976). The reader is also referred to the Gann Monograph on Cancer Research (Carter et al., 1976) which is devoted to articles on both fundamental and clinical studies.

Keywords

Thiazole Ring Lethal Damage Mouse Lymphoma Cell Bleomycin Treatment Deoxyribose Moiety 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

References to Addendum

  1. D’Andrea, A.D., Haseltine, W.A.: Sequence specific cleavage of DNA by the antitumor antibiotics neocarzinostatin and bleomycin. Proc. Natl. Acad. Sci. USA 75, 3608–3612 (1978)PubMedCrossRefGoogle Scholar
  2. Haidle, C.W.: Fragmentation of deoxyribonucleic acid by bleomycin. Mol. Pharmacol. 7, 645–652 (1971)PubMedGoogle Scholar
  3. Lloyd, R.S., Hewitt, R.R., Haidle, C.W.: Bleomycin-induced alkaline-labile damage and direct strand breakage in covalent-circular DNA. Fed. Proc. 36, 694 (1977)Google Scholar
  4. Lloyd, R.S., Haidle, C.W., Robberson, D.L.: Bleomycin-specific fragmentation of double-stranded DNA. Biochemistry 17, 1890–1896 (1978a)PubMedCrossRefGoogle Scholar
  5. Lloyd, R.S., Haidle, C.W., Robberson, D.L., Dodson, M.L. Jr.: A physical map of bleomycin-specific fragmentation sites on PM2 bacteriophage DNA. Current Microbiol. 1, 45–50 (1978 b)CrossRefGoogle Scholar
  6. Lloyd, R.S., Haidle, C.W., Hewitt, R.R.: Bleomycin-induced alkaline-labile damage and direct strand breakage of PM2 DNA. Cancer Res. 38, 3191–3196 (1978c)PubMedGoogle Scholar
  7. Lloyd, R.S., Haidle, C.W., Robberson, D.L.: Bleomycin-mediated interstrand cross-links in PM2 DNA. Fed. Proc. 37, 1670 (1978d)Google Scholar
  8. Lloyd, R.S., Haidle, C.W., Robberson, D.L.: Non-covalent intermolecular cross-links are produced by bleomycin reaction with duplex DNA. Proc. Natl. Acad. Sci. USA, in press (1979)Google Scholar
  9. Maxam, A.M., Gilbert, W.: A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA 74, 560–564 (1977)PubMedCrossRefGoogle Scholar
  10. Povirk, L.F., Wübker, W., Köhnlein, W., Hutchinson, F.: DNA double-strand breaks and alkalilabile bonds produced by bleomycin. Nucleic Acids Res. 4, 3573–3580 (1977)PubMedCrossRefGoogle Scholar
  11. Ross, S.L., Moses, R.E.: Two actions of bleomycin on superhelical DNA. Biochemistry 17, 581–586 (1978)PubMedCrossRefGoogle Scholar
  12. Sausville, E.A., Peisach, J., Horwitz, S.B.: A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem. Biophys. Res. Commun. 73, 814–822 (1976)PubMedCrossRefGoogle Scholar
  13. Sausville, E.A., Peisach, J., Horwitz, S.B.: Effect of chelating agents and metal ions on the degradation of DNA by bleomycin. Biochemistry 17, 2740–2746 (1978 a)PubMedCrossRefGoogle Scholar
  14. Sausville, E.A., Stein, R.W., Peisach, J., Horwitz, S.B.: Properties and products of the degradation of DNA by bleomycin and iron (II). Biochemistry 17, 2746–2754 (1978 b)PubMedCrossRefGoogle Scholar
  15. Takeshita, M., Grollman, A.P., Ohtsubo, E., Ohtsubo, H.: Interaction of bleomycin with DNA. Proc. Natl. Acad. Sci. USA 75, 5983–5987 (1978)PubMedCrossRefGoogle Scholar
  16. Takita, T., Muraoka, Y., Yoshioka, T., Fujii, A., Maeda, K., Umezawa, H.: The chemistry of bleomycin. IX. The structures of bleomycin and phleomycin. J. Antibiot. 25, 755–758 (1972)PubMedCrossRefGoogle Scholar
  17. Takita, T., Muraoka, Y., Nakatani, T., Fujii, A., Umezawa, Y., Naganawa, H., Umezawa, H.: Chemistry of bleomycin. XIX. Revised structures of bleomycin and phleomycin. J. Antibiot. 31, 801–804 (1978)PubMedCrossRefGoogle Scholar

References

  1. Alalawi, F.A., Chapman, I.V.: Combined effects of bleomycin and X-rays on DNA synthesis in asynchronous Ehrlich ascites cells in suspension. Br. J. Cancer 36, 78–83 (1977)PubMedCrossRefGoogle Scholar
  2. Aoki, H., Sakai, H.: Antiphage property as a screening test for antitumor agents. J. Antibiot. Ser. A 20, 87–92 (1967)Google Scholar
  3. Asakura, H., Hori, M., Umezawa, H.: Characterization of bleomycin action on DNA. J. Antibiot. 28, 537–542 (1975)PubMedCrossRefGoogle Scholar
  4. Bacchetti, S., Cassandro, M., Elli, R., Falchetti, R., Mauro, F.: Relationship between recovery from sublethal damage by dose fractionation and the restoration of viability after delayed plating in diploid Saccharomyces cerevisiae. Radiat. Res. 29, 295–315 (1966)PubMedCrossRefGoogle Scholar
  5. Barlogie, B., Drewinko, B., Schumann, J., Freireich, E.J.: Pulse cytophotometric analysis of cell cycle perturbation with bleomycin in vitro. Cancer Res. 36, 1182–1187 (1976)PubMedGoogle Scholar
  6. Barranco, S.C., Humphrey, R.M.: The effects of bleomycin on survival and cell progression in Chinese hamster cells in vitro. Cancer Res. 31, 1218–1223 (1971)PubMedGoogle Scholar
  7. Barranco, S.C., Humphrey, R.M.: The relevance of in vitro survival and cell cycle kinetics data to the clinical use of bleomycin. In: Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.), pp. 83–95. Baltimore, London, New York: University Park 1976Google Scholar
  8. Barranco, S.C., Novak, J.K., Humphrey, R.M.: Response of mammalian cells following treatment with bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea during plateau phase. Cancer Res. 33, 691–694 (1973)PubMedGoogle Scholar
  9. Barranco, S.C., Novak, J.K., Humphrey, R.M.: Studies on recovery from chemically induced damage in mammalian cells. Cancer Res. 35, 1194–1204 (1975)PubMedGoogle Scholar
  10. Bearden, J.C., Jr., Haidle, C.W.: Stimulation of bleomycin-induced fragmentation of DNA by intercalating agents. Biochem. Biophys. Res. Commun. 65, 371–377 (1975)PubMedCrossRefGoogle Scholar
  11. Bearden, J.C., Jr., Lloyd, R.S., Haidle, C.W.: Bleomycin-induced breakage of closed-circular DNA. Biochem. Biophys. Res. Commun. 75, 442–47 (1977)PubMedCrossRefGoogle Scholar
  12. Benedict, W.F., Banerjee, A., Gardner, A., Jones, P.A.: Induction of morphological transformation in mouse C3H/10T½ clone 8 cells and chromosomal damage in hamster A(T1)Cl-3 cells by cancer chemotherapeutic agents. Cancer Res. 37, 2202–2208 (1977)PubMedGoogle Scholar
  13. Bistro vie, M., Maricic, Z., Kolaric, K.: Interaction of bleomycin and radiation in combined treatment on mouse L cells. Int. J. Cancer 18, 540–542 (1976)PubMedCrossRefGoogle Scholar
  14. Bleehen, N.M., Gillies, N.E., Twentyman, P.R.: The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture. Br. J. Radiol. 47, 346–351 (1974)PubMedCrossRefGoogle Scholar
  15. Bode, V.C.: Single-strand scissions induced in circular and linear λ DNA by the presence of dithiothreitol and other reducing agents. J. Mol. Biol. 26, 125–129 (1967)PubMedCrossRefGoogle Scholar
  16. Bornstein, R.S., Hungerford, D.A., Haller, G., Engstrom, P.F., Yarbro, J.W.: Cytogenetic effects of bleomycin therapy in man. Cancer Res. 31, 2004–2007 (1971)PubMedGoogle Scholar
  17. Braun, J., Hahn, G.M.: Enhanced cell killing by bleomycin and 43° hyperthermia and the inhibition of recovery from potentially lethal damage. Cancer Res. 35, 2921–2927 (1975)PubMedGoogle Scholar
  18. Byfield, J.E., Lee, Y.C., Tu, L., Kulhanian, F.: Molecular interactions of the combined effects of bleomycin and X-rays on mammalian cell survival. Cancer Res. 36, 1138–1143 (1976)PubMedGoogle Scholar
  19. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.): Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin, p. 320. Baltimore, London, New York: University Park: 1976Google Scholar
  20. Chien, M., Grollman, A.P., Horwitz, S.B.: Bleomycin-DNA interactions: Fluorescence and proton magnetic resonance studies. Biochemistry 16, 3641–3647 (1977)CrossRefGoogle Scholar
  21. Clarkson, J.M., Humphrey, R.M.: The significance of damage in the cell cycle sensitivity of Chinese hamster ovary cells to bleomycin. Cancer Res. 36, 2345–2349 (1976)PubMedGoogle Scholar
  22. Coetzee, M.L., Sartiano, G.P., Klein, K., Ove, P.: Inhibition of bleomycin-induced [3H]thymidine 5′-triphosphate incorporation into liver and hepatoma nuclei by N-ethyl maleimide and daunomycin. J. Antibiot. 30, 163–171 (1977)PubMedCrossRefGoogle Scholar
  23. Cohen, S.S., I, J.: Synthesis and the lethality of bleomycin in bacteria. Cancer Res. 36, 2768–2774 (1976)PubMedGoogle Scholar
  24. Cox, R., Daoud, A.H., Irving, C.C.: Damage of rat liver deoxyribonucleic acid by bleomycin. Biochem. Pharmacol. 23, 3147–3151 (1974)PubMedCrossRefGoogle Scholar
  25. Crooke, S.T., Bradner, W.T.: Bleomycin, a review. J. Med. 7, 333–428 (1976)PubMedGoogle Scholar
  26. Desai, L.S., Krishan, A., Foley, G.E.: Effects of bleomycin on cells in culture: A quantitative cytochemical study. Cancer 34, 1873–1977 (1974)PubMedCrossRefGoogle Scholar
  27. DiCioccio, R., Srivastava, B.I.S.: Effect of bleomycin on deoxynucleotide-polymerizing enzymes from human cells. Cancer Res. 36, 1664–1668 (1976)PubMedGoogle Scholar
  28. Drewinko, B., Brown, B.W., Gottlieb, J.A.: The response of synchronized human lymphoma cells to bleomycin and 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res. 33, 2732–2336 (1973)PubMedGoogle Scholar
  29. Elkind, M.M., Sutton, H.: Radiation response of mammalian cells grown in culture. Radiat. Res. 13, 556–593 (1960)PubMedCrossRefGoogle Scholar
  30. Espejo, R.T., Canelo, E.S.: Properties of bacteriophage PM2: A lipid containing bacterial virus. Virology 34, 738–747 (1968)PubMedCrossRefGoogle Scholar
  31. Fernández-Gómez, M.E., De La Torre, C.: Action of bleomycin on proliferating plant cells. J. Antibiot. 29, 1096–1101 (1976)PubMedCrossRefGoogle Scholar
  32. Fujii, A., Takita, T., Shimada, M., Umezawa, H.: Biosyntheses of new bleomycins. J. Antibiot. 27, 13–71 (1974)CrossRefGoogle Scholar
  33. Fujimoto, J.: Radioautographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells. Cancer Res. 34, 2969–2974 (1974)PubMedGoogle Scholar
  34. Fujimoto, J., Higashi, H., Kosaki, G.: Intracellular distribution of [14C]bleomycin and the cytokinetic effects of bleomycin in the mouse tumor. Cancer Res. 36, 2248–2253 (1976)PubMedGoogle Scholar
  35. Fujiwara, Y., Kondo, T.: Strand-scission of HeLa cell deoxyribonucleic acid by bleomycin in vitro and in vivo. Biochem. Pharmacol. 22, 323–333 (1973)PubMedCrossRefGoogle Scholar
  36. Hahn, G.M.: Recovery of cells from induced, potentially lethal damge. Cancer Treat. Rep. 60, 1791–1798 (1976)PubMedGoogle Scholar
  37. Haidle, C.W.: Fragmentation of deoxyribonucleic acid by bleomycin. Mol. Pharmacol. 7, 645–652 (1971)PubMedGoogle Scholar
  38. Haidle, C.W., Bearden, J., Jr.: Effect of bleomycin on an RNA-DNA hybrid. Biochem. Biophys. Res. Commun. 65, 815–821 (1975)PubMedCrossRefGoogle Scholar
  39. Haidle, C.W., Kuo, M.T., Weiss, K.K.: Nucleic acid-specificity of bleomycin. Biochem. Pharmacol. 21, 3308–3312 (1972a)PubMedCrossRefGoogle Scholar
  40. Haidle, C.W., Weiss, K.K., Kuo, M.T.: Release of free bases from deoxyribonucleic acid after reaction with bleomycin. Mol. Pharmacol. 8, 531–537 (1972b)PubMedGoogle Scholar
  41. Haidle, C.W., Weiss, K.K., Mace, M.L., Jr.: Induction of bacteriophage by bleomycin. Biochem. Biophys. Res. Commun. 48, 1179–1184 (1972c)PubMedCrossRefGoogle Scholar
  42. Hittelman, W.M., Rao, P.N.: Bleomycin-induced damage in prematurely condensed chromosomes and its relationship to cell cycle progression in CHO cells. Cancer Res. 34, 3433–3439 (1974)PubMedGoogle Scholar
  43. Ichikawa, T.: Studies of bleomycin: Discovery of its clinical effect, combination treatment with bleomycin and radiotherapy, side effects, and long term survival. In: Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.), pp. 99–115. Baltimore, London, New York: University Park: 1976Google Scholar
  44. Iqbal, Z.M., Kohn, K.W., Ewig, R.A.G., Fornace, A.J., Jr.: Single-strand scission and repair of DNA in mammalian cells by bleomycin. Cancer Res. 36, 3834–3838 (1976)PubMedGoogle Scholar
  45. Ishida, R., Takahashi, T.: Increased DNA chain breakage by combined action of bleomycin and Superoxide radical. Biochem. Biophys. Res. Commun. 66, 1432–1438 (1975)PubMedCrossRefGoogle Scholar
  46. Ishizuka, M., Takayama, H., Takeuchi, T., Umezawa, H.: Activity and toxicity of bleomycin. J. Antibiot. Ser. A 20, 15–24 (1967)Google Scholar
  47. Kohn, K.W., Ewig, R.A.G.: Effect of pH on the bleomycin-induced DNA single-strand scission in L1210 cells and the relation to cell survival. Cancer Res. 36, 3839–3841 (1976)PubMedGoogle Scholar
  48. Krishan, A.: Bleomycin-induced fine structural alterations in cultured mouse fibroblasts and human lymphocytes of neoplastic origin. Cancer Res. 33, 777–785 (1973)PubMedGoogle Scholar
  49. Krueger, W.C., Pschigoda, L.M., Reusser, F.: Interaction of DNA with zorbamycin, phleomycin and bleomycin, Ultraviolet absorption and circular dichroism measurements. J. Antibiot. 26, 424–428 (1973)PubMedCrossRefGoogle Scholar
  50. Kunimoto, T., Hori, M., Umezawa, H.: Modes of action of phleomycin, bleomycin, and formycin on HeLa S3 cells in synchronized culture. J. Antibiot. Ser. A 20, 277–281 (1967)Google Scholar
  51. Kuo, M.T.: Effects of bleomycin on DNA and mammalian chromosomes. Doctoral Dissertation. The University of Texas Health Science Center at Houston, Graduate School of Biomedical Sciences, 1973Google Scholar
  52. Kuo, M.T., Haidle, C.W.: Characterization of chain breakage in DNA induced by bleomycin. Biochim. Biophys. Acta 385, 109–114 (1973)Google Scholar
  53. Kuo, M.T., Haidle, C.W., Inners, L.D.: Characterization of bleomycin-resistant DNA. Biophys. J. 13, 1296–1306 (1973)CrossRefGoogle Scholar
  54. Kuo, M.T., Auger, L.T., Saunders, G.F., Haidle, C.W.: Effect of bleomycin on the synthesis and function of RNA. Cancer Res. 37, 1345–1348 (1977)PubMedGoogle Scholar
  55. Lapi, L., Cohen, S.S.: Inhibition of the lethality of bleomycin A5 in L-cells by hirudonine. Cancer Res. 37, 1384–1388 (1977)PubMedGoogle Scholar
  56. Lloyd, R.S., Hewitt, R.R., Haidle, C.W.: Bleomycin-induced alkaline-labile damage and direct strand breakage in covalent-circular DNA. Fed. Proc. 36, 694 (1977)Google Scholar
  57. Lown, J.W., Sim, S.-K.: The mechanism of the bleomycin-induced cleavage of DNA. Biochem. Biophys. Res. Commun. 77, 1150–1157 (1977)PubMedCrossRefGoogle Scholar
  58. Matsuzawa, T., Onozawa, M., Morita, K., Kakehi, M.: Radiosensitization of bleomycin on lethal effect of mouse cancer cell in vitro. Strahlentherapie 144, 614–617 (1972)PubMedGoogle Scholar
  59. Mauro, F., Falpo, B., Briganti, G., Elli, R., Zupi, G.: Effects of antineoplastic drugs on plateau-phase cultures of mammalian cells. II. Effects of bleomycin and hydroxyurea. J. Natl. Cancer Inst. 52, 715–722 (1974)PubMedGoogle Scholar
  60. Miyaki, M., Ono, T.: Mechanism of action of bleomycin. In: Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.), pp. 37–50. Baltimore, London, New York: University Park 1976Google Scholar
  61. Miyaki, M., Ono, T., Umezawa, H.: Inhibition of ligase reaction by bleomycin. J. Antibiot. 24, 587–592 (1971)PubMedCrossRefGoogle Scholar
  62. Miyaki, M., Morohasi, S., Ono, T.: Single strand scission and repair of DNA in bleomycin-sensitive and resistant rat ascites hepatoma cells. J. Antibiot. 26, 369–373 (1973)PubMedCrossRefGoogle Scholar
  63. Miyaki, M., Kitayama, T., Ono, T.: Breakage of DNA-membrane complex by bleomycin. J. Antibiot. 27, 647–655 (1974)PubMedCrossRefGoogle Scholar
  64. Miyaki, M., Ono, R., Hori, S., Umezawa, H.: Binding of bleomycin to DNA in bleomycin-sensitive and -resistant rat ascites hepatoma cells. Cancer Res. 55, 2015–2019 (1975)Google Scholar
  65. Müller, W.E.G., Zahn, R.K.: Bleomycin: Mode of action on DNA. In: Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.), pp. 51–62. Baltimore, London, New York: University Park 1976 aGoogle Scholar
  66. Müller, W.E.G., Zahn, R.K.: Effect of bleomycin on DNA, RNA, protein, chromatin and on cell transformation by oncogenic RNA viruses. Prog. Biochem. Pharmacol. 11, 28–47 (1976 b)PubMedGoogle Scholar
  67. Müller, W.E.G., Zahn, R.K.: Determination of the bleomycin-inactivation enzyme in biopsies. Gann 67, 425–430 (1976c)PubMedGoogle Scholar
  68. Müller, W.E.G., Zahn, R.K.: Bleomycin, an antibiotic that removes thymine from double-stranded DNA. Prog. Nucl. Acid. Res. Mol. Biol. 40, 21–57 (1977)CrossRefGoogle Scholar
  69. Müller, W.E.G., Yamazaki, Z., Breter, H.-J., Zahn, R.K.: Action of bleomycin on DNA and RNA. Eur. J. Biochem. 31, 518–525 (1972a)PubMedCrossRefGoogle Scholar
  70. Müller, W.E.G., Yamazaki, Z., Zahn, R.K.: Bleomycin, a selective inhibitor of DNA dependent DNA polymerase from oncogenic RNA viruses Biochem. Biophys. Res. Commun. 46, 1667–1673 (1972 b)CrossRefGoogle Scholar
  71. Müller, W.E.G., Yamazaki, Z., Zöllner, J.E., Zahn, R.K.: Action of bleomycin on programmed synthesis influence on DNA and RNA nucleases. FEBS Lett. 31, 217–221 (1973)PubMedCrossRefGoogle Scholar
  72. Müller, W.E.G., Totsuka, A., Nusser, I., Zahn, R.K., Umezawa, H.: Bleomycin inhibition of DNA synthesis in isolated enzyme systems and in intact cell systems. Biochem. Pharmacol. 24, 911–915(1975)PubMedCrossRefGoogle Scholar
  73. Müller, W.E.G., Rohde, H.J., Steffen, R., Maidhof, A., Zahn, R.K.: Potentiation of the effectiveness of bleomycin by A·T-specific DNA ligands in vitro as well as in vivo. Cancer Lett. 1, 127–132 (1976 a)CrossRefGoogle Scholar
  74. Müller, W.E.G., Rohde, H.J., Zahn, R.K.: Effect of bleomycin on DNA, RNA, enzymes, chromatin and on local sarcoma. J. Mol. Med. 1, 173–186 (1976b)Google Scholar
  75. Murakami, H., Mori, H., Taira, S.: Active centre model on the structure and function of the bleomycin molecule as the prototype of esteratic enzymes. J. Theor. Biol. 42, 443–460 (1973)PubMedCrossRefGoogle Scholar
  76. Murakami, H., Mori, H., Taira, S.: On the molecular embrace of bleomycin with helical DNA. J. Theor. Biol. 59, 1–23 (1976)PubMedCrossRefGoogle Scholar
  77. Nagai, K., Suzuki, H., Tanaka, N., Umezawa, H.: Decrease of melting temperature and single-strand scission of DNA by bleomycin in the presence of 2-mercaptoethanol. J. Antibiot. 22, 569–573 (1969 a)PubMedCrossRefGoogle Scholar
  78. Nagai, K., Yamaki, H., Suzuki, H., Tanaka, N., Umezawa, H.: The combined effects of bleomycin and sulfhydryl compounds on the thermal denaturation of DNA. Biochim. Biophys. Acta 179, 165–171 (1969b)PubMedGoogle Scholar
  79. Nagatsu, M., Richert, R.M., Lambert, A.: Effects of bleomycin on the cell cycle of Ehrlich ascites carcinoma. Cancer Res. 32, 1966–1970 (1972)PubMedGoogle Scholar
  80. Nunn, A.D.: Interactions between bleomycins and metals. J. Antibiot. 29, 1102–1108 (1976)PubMedCrossRefGoogle Scholar
  81. Ogawa, K., Onoé, T.: Nuclear changes produced by bleomycin in the 3-methyl-cholanthrene-induced mouse epidermal carcinoma cells. Gann 60, 503–507 (1969)PubMedGoogle Scholar
  82. Ohama, K., Kadotani, T.: Cytologic effects of bleomycin on cultured human leucocytes. Jpn. J. Human Genet. 14, 293–297 (1970)Google Scholar
  83. Onishi, T., Shimada, K., Takagi, Y.: Effects of bleomycin on Escherichia coli strains with various sensitivities to radiations. Biochim. Biophys. Acta 312, 248–258 (1973)PubMedGoogle Scholar
  84. Onishi, T., Iwata, H., Takagi, Y.: Effects of reducing and oxidizing agents on the action of bleomycin. J. Biochem. 77, 745–752 (1975)PubMedGoogle Scholar
  85. Osieka, R., Madreiter, H., Schmidt, C.G.: The effect of bleomycin on mitochondrial DNA. Z. Krebsforsch. 88, 11–15 (1976)Google Scholar
  86. Paika, K.D., Krishan, A.: Bleomycin-induced chromosomal aberrations in cultured mammalian cells. Cancer Res. 33, 961–965 (1973)PubMedGoogle Scholar
  87. Perry, P., Evans, H.J.: Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange. Nature (London) 258, 121–125 (1975)CrossRefGoogle Scholar
  88. Phillips, R.A., Tolmach, L.J.: Repair of potentially lethal damage in X-irradiated HeLa cells. Radiat. Res. 29, 413–432 (1966)PubMedCrossRefGoogle Scholar
  89. Promchainant, C.: Cytogenetic effect of bleomycin on human leukocytes in vitro. Mutat. Res. 28, 107–112(1975)PubMedCrossRefGoogle Scholar
  90. Ray, G.R., Hahn, G.M., Bagshaw, M.A., Kurkjian, S.: Cell survival and repair of plateau-phase cultures after chemotherapy — relevance to tumor therapy and to the in vitro screening of new agents. Cancer Chemother. Rep. Part 1 57, 473–475 (1973)Google Scholar
  91. Reddy, S.B., Linden, W.A., Zywietz, F., Baish, H., Struck, U.: Effects of acronycine, bleomycin and cytosine arabinoside on the cell cycle. Arzneimittelforschung/Drug Res. 27, 1549–1553 (1977)Google Scholar
  92. Ross, S.L., Moses, R.E.: Effect of bleomycin on deoxyribonucleic acid synthesis in toluene-treated Escherichia coli cells. Antimicrob. Agents Chemother. 9, 239–246 (1976)PubMedCrossRefGoogle Scholar
  93. Saito, M., Andoh, T.: Breakage of a DNA-protein complex induced by bleomycin and their repair in cultured mouse fibroblasts. Cancer Res. 33, 1696–1700 (1973)PubMedGoogle Scholar
  94. Sartiano, G.P., Winklestein, A.; Lynch, W.E., Boggs, S.S.: Effects of bleomycin on PHA-stimulated lymphocytes and isolated hepatic nuclei. J. Antibiot. 26, 437–443 (1973)PubMedCrossRefGoogle Scholar
  95. Sartiano, G.P., Lynch, W., Boggs, S.S., Neil, G.L.: The demonstration of separate DNA polymerase activities in intact isolated rat liver nuclei by means of response to bleomycin and arabinosyl cytosine 5′-triphosphate. Proc. Soc. Exp. Biol. Med. 150, 718–722 (1975)PubMedGoogle Scholar
  96. Sartiano, G.P., Coetzee, M.L., Klein, K., Ove, P.: Effect of camptothecin and adriamycin on bleomycin-induced tritiated thymidine triphosphate incorporation in a rat nuclear system. J. Natl. Cancer Inst. 58, 1357–1364 (1977)PubMedGoogle Scholar
  97. Saunders, P.P., Schultz, G.A.: Mechanism of action of bleomycin-I Bacterial growth studies. Biochem. Pharmacol. 21, 1657–1666 (1972)PubMedCrossRefGoogle Scholar
  98. Sausville, E.A., Peisach, J., Horwitz, S.B.: A role for ferrous ion and oxygen in the degradation of DNA by bleomycin. Biochem. Biophys. Res. Commun. 73, 814–822 (1976)PubMedCrossRefGoogle Scholar
  99. Shirakawa, I., Azegami, M., Ishii, S.-I., Umezawa, H.: Reaction of bleomycin with DNA strand scission of DNA in the absence of sulfhydryl or peroxide compounds. J. Antibiot. 24, 761–766 (1971)PubMedCrossRefGoogle Scholar
  100. Shishido, K.: Differential inhibition of transcriptions catalyzed by T7-specific and Escherichia coli RNA polymerases by bleomycin. J. Antibiot. 26, 501–505 (1973)PubMedCrossRefGoogle Scholar
  101. Spangler, M., Sartiano, G.P., Coetzee, M.L., Ove, P.: Effect of bleomycin on [3H]thymidine 5′-triphosphate incorporation into host liver and hepatoma nuclei. Cancer Res. 36, 1339–1346 (1976)PubMedGoogle Scholar
  102. Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., Umezawa, H.: Mechanism of action of bleomycin. Studies with the growing culture of bacterial and tumor cells. J. Antibiot. 21, 379–386 (1968)PubMedCrossRefGoogle Scholar
  103. Suzuki, H., Nagai, K., Yamaki, H., Tanaka, N., Umezawa, H.: On the mechanism of action of bleomycin: Scission of DNA strands in vitro and in vivo. J. Antibiot. 22, 446–448 (1969)PubMedCrossRefGoogle Scholar
  104. Suzuki, H., Nagai, K., Akutsu, E., Yamaki, H., Tanaka, N., Umezawa, H.: On the mechanism of action of bleomycin strand scission of DNA caused by bleomycin and its binding to DNA in vitro. J. Antibiot. 23, 473–480 (1970)PubMedCrossRefGoogle Scholar
  105. Takeshita, M., Horwitz, S.B., Grollman, A.P.: Bleomycin, an inhibitor of vaccinia virus replication. Virology 60, 455–465 (1974)PubMedCrossRefGoogle Scholar
  106. Takeshita, M., Grollman, A.P., Horwitz, S.B.: Effect of ATP and other nucleotides on the bleomycin-induced degradation of vaccinia virus DNA. Virology 69, 453–463 (1976)PubMedCrossRefGoogle Scholar
  107. Takita, T., Muraoka, Y., Fujii, A., Itoh, H., Maeda, K., Umezawa, H.: The structure of the sulfur-containing chromophore of phleomycin, and the chemical transformation of phleomycin to bleomycin. J. Antibiot. 25, 197–199 (1972a)PubMedCrossRefGoogle Scholar
  108. Takita, T., Muraoka, Y., Yoshioka, T., Fujii, A., Maeda, K., Umezawa, H.: The chemistry of bleomycin. IX. The structures of bleomycin and phleomycin. J. Antibiot. 25, 755–758 (1972 b)PubMedCrossRefGoogle Scholar
  109. Takita, T., Fujii, A., Fukuoka, T., Umezawa, H.: Chemical cleavage of bleomycin to bleomycinic acid and synthesis of new bleomycins. J. Antibiot. 26, 252–254 (1973)PubMedCrossRefGoogle Scholar
  110. Tamura, H., Sugiyama, Y., Sugahara, T.: Effect of bleomycin on the chromosomes of human lymphocytes at various cell phases. Gann 65, 103–107 (1974)PubMedGoogle Scholar
  111. Tanaka, N.: Inhibition of transcription by pluramycin and bleomycin. J. Antibiot. 23, 523–530 (1970)PubMedCrossRefGoogle Scholar
  112. Terasima, T., Umezawa, H.: Lethal effect of bleomycin on cultured mammalian cells. J. Antibiot. 23, 300–304 (1970)PubMedCrossRefGoogle Scholar
  113. Terasima, T., Takabe, Y., Katsumata, T., Watanabe, M., Umezawa, H.: Effect of bleomycin on mammalian cell survival. J. Natl. Cancer Inst. 49, 1093–1100 (1972)PubMedGoogle Scholar
  114. Terasima, T., Watanabe, M., Takabe, Y., Miyamoto, T.: Action of bleomycin on proliferative capacity of mammalian cells. In: Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.), pp. 63–81. Baltimore, London, New York: University Park 1976Google Scholar
  115. Tobey, R.A.: Arrest of Chinese hamster cells in G2 following treatments with the anti-tumor drug bleomycin. J. Cell. Physiol. 79, 259–266 (1972a)PubMedCrossRefGoogle Scholar
  116. Tobey, R.A.: A simple, rapid technique for determination of the effects of chemotherapeutic agents on mammalian cell-cycle traverse. Cancer Res. 32, 309–316 (1972 b)PubMedGoogle Scholar
  117. Totsuka, A., Müller, W.E.G., Zahn, R.K.: Bleomycin: Action on growth of oncogenic RNA viruses and on cell transformation. Arch. Virol. 48, 169–179 (1975)CrossRefGoogle Scholar
  118. Twentyman, P.R.: Comparative chemosensitivity of exponential- versus pleateu-phase cells in both in vitro and in vivo model systems. Cancer Treat. Rep. 60, 1719–1722 (1976 a)PubMedGoogle Scholar
  119. Twentyman, P.R.: The effect of bleomycin and pentamycin in combination on the survival of EMT6 mouse tumor cells in vitro and in vivo. Br. J. Cancer 33, 459–464 (1976 b)PubMedCrossRefGoogle Scholar
  120. Twentyman, P.R., Bleehen, N.M.: The sensitivity of cells in exponential and stationary phases of growth to bleomycin and to 1,3-bis(2-chloroethyl)-1-nitrosurea. Br. J. Cancer 28, 500–507(1973)PubMedCrossRefGoogle Scholar
  121. Twentyman, P.R., Bleehen, N.M.: Changes in sensitivity to radiation and to bleomycin occurring during the life history of monolayer cultures of a mouse tumor cell line. Br. J. Cancer 31, 68–74 (1975a)PubMedGoogle Scholar
  122. Twentyman, P.R., Bleehen, N.H.: Studies of “potentially lethal damage” in EMT6 mouse tumor cells treated with bleomycin either in vitro or in vivo. Br. J. Cancer 32, 491–501 (1975 b)PubMedCrossRefGoogle Scholar
  123. Umezawa, H.: Bleomycin. In: Antibiotics. Mechanism of action of antimicrobial and antitumor agents. Corcoran, J.W., Hahn, F.E. (eds.), Vol. III, pp. 21–33. Berlin, Heidelberg, New York: Springer 1975CrossRefGoogle Scholar
  124. Umezawa, H.: Bleomycin: Discovery, chemistry, and action. In: Gann monograph on cancer research No. 19. Fundamental and clinical studies of bleomycin. Carter, S.K., Ichikawa, T., Mathé, G., Umezawa, H. (eds.), pp. 3–36. Baltimore, London, New York: University Park 1976Google Scholar
  125. Umezawa, H., Maeda, K., Takeuchi, T., Okami, Y.: New antibiotics, bleomycin A and B. J. Antibiot. Ser. A 19, 200–209 (1966 a)Google Scholar
  126. Umezawa, H., Suhara, Y., Takita, T., Maeda, K.: Purification of bleomycins. J. Antibiot. Ser. A 19, 210–215 (1966b)Google Scholar
  127. Umezawa, H., Ishizuka, M., Maeda, K., Takeuchi, T.: Studies on bleomycin. Cancer 20, 891–895 (1967)PubMedCrossRefGoogle Scholar
  128. Umezawa, H., Ishizuka, M., Hori, S., Chimura, H., Takeuchi, T.: The distribution of 3H-bleomycin in mouse tissue. J. Antibiot. 21, 638–642 (1968 a)PubMedCrossRefGoogle Scholar
  129. Umezawa, H., Ishizuka, M., Kimura, K., Iwanaga, J., Takeuchi, T.: Biological studies on individual bleomycin. J. Antibiot. 21, 592–602 (1968 b)PubMedCrossRefGoogle Scholar
  130. Umezawa, H., Asakura, H., Oda, K., Hori, S., Hori, M.: The effect of bleomycin on SV40 DNA: Characteristics of bleomycin action which produces a single scission in a superhelical form of SV40 DNA. J. Antibiot. 26, 521–527 (1973)PubMedCrossRefGoogle Scholar
  131. Watanabe, M., Takabe, Y., Katsumata, T., Terasima, T., Umezawa, H.: Response in macromolecular syntheses of mouse L cells to bleomycin, with special reference to cell-antibiotic interaction. J. Antibiot. 26, 417–23 (1973)PubMedCrossRefGoogle Scholar
  132. Watanabe, M., Takabe, Y., Katsumata, T., Terasima, T.: Effects of bleomycin on progression through the cell cycle of mouse L-cells. Cancer Res. 34, 878–881 (1974)PubMedGoogle Scholar
  133. Wheatley, D.N., Muller, G.C., Kajiwara, K.: Anti-mitotic activity of bleomycin: Time of action in the mammalian cell cycle. Br. J. Cancer 29, 117–131 (1974)PubMedCrossRefGoogle Scholar
  134. Yamaki, H., Suzuki, H., Nagai, K., Tanaka, N., Umezawa, H.: Effects of bleomycin A2 on deoxyribonuclease, DNA polymerase and ligase reactions. J. Antibiot. 24, 178–184 (1971)PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1979

Authors and Affiliations

  • C. W. Haidle
  • R. S. Lloyd

There are no affiliations available

Personalised recommendations